Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients

被引：0
作者：
Rossana Tallerico
Costanza M Cristiani
Mariaelena Capone
Gabriele Madonna
Domenico Mallardo
Ester Simeone
Andrea Dominijanni
Antonio M Grimaldi
Francesco Colucci
Paolo A Ascierto
Ennio Carbone
机构：
[1] University "Magna Graecia" of Catanzaro,Tumorimmunology and Immunopathology Laboratory, Department of Experimental and Clinic Medicine
[2] Istituto Nazionale Tumori Fondazione "G. Pascale",Melanoma. CancerImmunotherapy and Innovative Therapy Unit
[3] Immunohaematological Transfusion Medicine Centre “Pugliese-Ciaccio” Hospital of Catanzaro,Department of Obstetrics and Gynaecology
[4] University of Cambridge Clinical School,Department of Microbiology Cell and Tumorbiology (MTC)
[5] Karolinska Institutet,undefined
来源：
Journal of Translational Medicine | / 13卷 / Suppl 1期
关键词：
Melanoma; Metastatic Melanoma; Melanoma Patient; Ipilimumab; Cell Immune Response;
D O I：
10.1186/1479-5876-13-S1-O8
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] TIGIT+ NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patients
    Tsakmaklis, Anastasia
    Farowski, Fedja
    Zenner, Rafael
    Lesker, Till Robin
    Strowig, Till
    Schloesser, Hans
    Lehmann, Jonas
    von Bergwelt-Baildon, Michael
    Mauch, Cornelia
    Schlaak, Max
    Knuever, Jana
    Schweinsberg, Viola
    Heinzerling, Lucie M.
    Vehreschild, Maria J. G. T.
    BMC CANCER, 2023, 23 (01)
  • [42] Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies
    Du Four, Stephanie
    Wilgenhof, Sofie
    Duerinck, Johnny
    Michotte, Alex
    Van Binst, Anne
    De Ridder, Mark
    Neyns, Bart
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (16) : 3045 - 3051
  • [43] Biomarkers on melanoma patient T Cells associated with ipilimumab treatment
    Wenshi Wang
    Daohai Yu
    Amod A Sarnaik
    Bin Yu
    Maclean Hall
    Dawn Morelli
    Yonghong Zhang
    Xiuhua Zhao
    Jeffrey S Weber
    Journal of Translational Medicine, 10
  • [44] Biomarkers on melanoma patient T Cells associated with ipilimumab treatment
    Wang, Wenshi
    Yu, Daohai
    Sarnaik, Amod A.
    Yu, Bin
    Hall, Maclean
    Morelli, Dawn
    Zhang, Yonghong
    Zhao, Xiuhua
    Weber, Jeffrey S.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [45] Treatment of in-transit and metastatic melanoma in two patients treated with ipilimumab and topical imiquimod
    Joseph, Richard W.
    Cappel, Mark
    Tzou, Katherine
    Bagaria, Sanjay
    Gilstrap, Cheryl
    Swaika, Abhisek
    Jambusaria-Pahlajani, Anokhi
    MELANOMA RESEARCH, 2016, 26 (04) : 409 - 412
  • [46] A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab
    Chandra, Ravi A.
    Wilhite, Tyler J.
    Balboni, Tracy A.
    Alexander, Brian M.
    Spektor, Alexander
    Ott, Patrick A.
    Ng, Andrea K.
    Hodi, F. Stephen
    Schoenfeld, Jonathan D.
    ONCOIMMUNOLOGY, 2015, 4 (11):
  • [47] Pretreatment Serum VEGF Is Associated with Clinical Response and Overall Survival in Advanced Melanoma Patients Treated with Ipilimumab
    Yuan, Jianda
    Zhou, Jun
    Dong, Zhiwan
    Tandon, Sapna
    Kuk, Deborah
    Panageas, Katherine S.
    Wong, Philip
    Wu, Xinqi
    Naidoo, Jarushka
    Page, David B.
    Wolchok, Jedd D.
    Hodi, F. Stephen
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (02) : 127 - 132
  • [48] Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab
    Tobin, Richard P.
    Jordan, Kimberly R.
    Robinson, William A.
    Davis, Dana
    Borges, Virginia F.
    Gonzalez, Rene
    Lewis, Karl D.
    McCarter, Martin D.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 63 : 282 - 291
  • [49] Toxicity and response to ipilimumab and nivolumab in older patients with metastatic melanoma: A multicentre retrospective analysis
    Pathmanathan, Shivanshan
    Babu, Hari
    Dzienis, Marcin
    Azer, Mary
    Eastgate, Melissa
    PIGMENT CELL & MELANOMA RESEARCH, 2022, 35 (06) : 587 - 594
  • [50] Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab
    Ma, Vincent T.
    Perera, Alahendra A. Chamila
    Sun, Yilun
    Sitto, Merna
    Waninger, Jessica J.
    Warrier, Govind
    Green, Michael D.
    Fecher, Leslie A.
    Lao, Christopher D.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345